Product Datasheet
Pyruvate Dehydrogenase E1 beta subunit Antibody
Catalog Number: 49646
Technical:tech@swbio.com
Information:info@swbio.com
Description
- Swiss-Prot No.:
- Swiss-Prot#:P11177
- Form of Antibody:
- 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
- Immunogen:
- Recombinant protein
- appl_detail:
- WB: 1:500-1:2,000
IHC: 1:50-1:200
FC: 1:50-1:100
- other_names:
- DKFZp564K0164 antibody
mitochondrial antibody
ODPB_HUMAN antibody
pdhB antibody
PDHBD antibody
PDHE1 B antibody
PDHE1-B antibody
PHE1B antibody
Pyruvate dehydrogenase (lipoamide) beta
- Purification:
- ProA affinity purified
- Applications:
- WB, IHC, IP, FC
- Background:
- The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO. It contains multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3). Defects in PDHB are a cause of pyruvate dehydrogenase E1 component deficiency (PDHE1 deficiency). PDHE1 deficiency is the most common enzyme defect in patients with primary lactic acidosis. It is associated with variable clinical phenotypes ranging from neonatal death to prolonged survival complicated by developmental delay, seizures, ataxia, apnea, and in some cases to an X-linked form of Leigh syndrome (LS) (Leigh encephalomyelopathy).
© Signalway Biotechnology All Rights Reserved.